Replies to post #89075 on Biotech Values

[DewDiligence]

What’s a little acetate among friends? :-)

Seriously, this was a badly conceived blog apart from the manifold English mistakes. The thesis that Teva’s Lovenox ANDA is a hedge against loss of Copaxone exclusivity is just plain silly, IMO.